Nuvectis Pharma, Inc. (NVCT) Tops Q3 EPS by 1c

Nuvectis Pharma, Inc. (NASDAQ: NVCT) reported Q3 EPS of ($0.24), $0.01 better than the analyst estimate of ($0.25).

For earnings history and earnings-related data on Nuvectis Pharma, Inc. (NVCT) click here.

You May Also Be Interested In

• S&P Dow Jones Indices adds Bloom Energy to S&P 500 index
• Arcosa stockholders approve $150-per-share cash buyout by CRH
• S&P announces major changes in S&P 100, S&P 500, S&P 400